The World Health Organisation has issued a warning concerning four medicines produced by Delhi-based Maiden Pharmaceuticals.
Since July, at least 66 infants have died in Gambia as a result of acute kidney injury, according to the WHO.
The deaths of 66 children from kidney injuries may be linked to four cough and cold syrups made by an Indian drug manufacturer, the World Health Organization (WHO) said on Wednesday.
WHO Director-General Tedros Adhanom Ghebreyesus said the UN’s health agency was conducting investigations along with Indian regulators and India’s Maiden Pharmaceuticals.
[wonderplugin_video iframe=”https://youtu.be/othGdXmc04o” lightbox=0 lightboxsize=1 lightboxwidth=960 lightboxheight=540 autoopen=0 autoopendelay=0 autoclose=0 lightboxtitle=”” lightboxgroup=”” lightboxshownavigation=0 showimage=”” lightboxoptions=”” videowidth=600 videoheight=400 keepaspectratio=1 autoplay=0 loop=0 videocss=”position:relative;display:block;background-color:#000;overflow:hidden;max-width:100%;margin:0 auto;” playbutton=”https://www.tvcnews.tv/wp-content/plugins/wonderplugin-video-embed/engine/playvideo-64-64-0.png”]
The WHO issued a medical product alert, requesting that four medications manufactured by Maiden Pharmaceuticals be removed off the market.
The medicines have only been identified in Gambia, according to the alert, although they may have been distributed in other nations via informal marketplaces.
The four products identified by the alert were: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.
The UN agency said its lab analysis confirmed the presence of “unacceptable” amounts of diethylene glycol and ethylene glycol.
The alert said that the two substances are toxic to humans and can cause acute kidney injury.
“To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the alert said.
A spike in cases of acute kidney injury among children under the age of five was detected in Gambia in late July.
The government in Banjul announced last month that it was investigating the deaths, and the country’s Health Ministry ordered hospitals to discontinue the use of syrup-based paracetamol treatment after at least 28 children died of kidney failure.
Gambia is already struggling with a number of public health crises, including measles and malaria.
The World Health Organisation has issued a warning concerning four medicines produced by Delhi-based Maiden Pharmaceuticals.
Since July, at least 66 infants have died in Gambia as a result of acute kidney injury, according to the WHO.
The deaths of 66 children from kidney injuries may be linked to four cough and cold syrups made by an Indian drug manufacturer, the World Health Organization (WHO) said on Wednesday.
WHO Director-General Tedros Adhanom Ghebreyesus said the UN’s health agency was conducting investigations along with Indian regulators and India’s Maiden Pharmaceuticals.
[wonderplugin_video iframe=”https://youtu.be/othGdXmc04o” lightbox=0 lightboxsize=1 lightboxwidth=960 lightboxheight=540 autoopen=0 autoopendelay=0 autoclose=0 lightboxtitle=”” lightboxgroup=”” lightboxshownavigation=0 showimage=”” lightboxoptions=”” videowidth=600 videoheight=400 keepaspectratio=1 autoplay=0 loop=0 videocss=”position:relative;display:block;background-color:#000;overflow:hidden;max-width:100%;margin:0 auto;” playbutton=”https://www.tvcnews.tv/wp-content/plugins/wonderplugin-video-embed/engine/playvideo-64-64-0.png”]
The WHO issued a medical product alert, requesting that four medications manufactured by Maiden Pharmaceuticals be removed off the market.
The medicines have only been identified in Gambia, according to the alert, although they may have been distributed in other nations via informal marketplaces.
The four products identified by the alert were: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.
The UN agency said its lab analysis confirmed the presence of “unacceptable” amounts of diethylene glycol and ethylene glycol.
The alert said that the two substances are toxic to humans and can cause acute kidney injury.
“To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the alert said.
A spike in cases of acute kidney injury among children under the age of five was detected in Gambia in late July.
The government in Banjul announced last month that it was investigating the deaths, and the country’s Health Ministry ordered hospitals to discontinue the use of syrup-based paracetamol treatment after at least 28 children died of kidney failure.
Gambia is already struggling with a number of public health crises, including measles and malaria.
The World Health Organisation has issued a warning concerning four medicines produced by Delhi-based Maiden Pharmaceuticals.
Since July, at least 66 infants have died in Gambia as a result of acute kidney injury, according to the WHO.
The deaths of 66 children from kidney injuries may be linked to four cough and cold syrups made by an Indian drug manufacturer, the World Health Organization (WHO) said on Wednesday.
WHO Director-General Tedros Adhanom Ghebreyesus said the UN’s health agency was conducting investigations along with Indian regulators and India’s Maiden Pharmaceuticals.
[wonderplugin_video iframe=”https://youtu.be/othGdXmc04o” lightbox=0 lightboxsize=1 lightboxwidth=960 lightboxheight=540 autoopen=0 autoopendelay=0 autoclose=0 lightboxtitle=”” lightboxgroup=”” lightboxshownavigation=0 showimage=”” lightboxoptions=”” videowidth=600 videoheight=400 keepaspectratio=1 autoplay=0 loop=0 videocss=”position:relative;display:block;background-color:#000;overflow:hidden;max-width:100%;margin:0 auto;” playbutton=”https://www.tvcnews.tv/wp-content/plugins/wonderplugin-video-embed/engine/playvideo-64-64-0.png”]
The WHO issued a medical product alert, requesting that four medications manufactured by Maiden Pharmaceuticals be removed off the market.
The medicines have only been identified in Gambia, according to the alert, although they may have been distributed in other nations via informal marketplaces.
The four products identified by the alert were: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.
The UN agency said its lab analysis confirmed the presence of “unacceptable” amounts of diethylene glycol and ethylene glycol.
The alert said that the two substances are toxic to humans and can cause acute kidney injury.
“To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the alert said.
A spike in cases of acute kidney injury among children under the age of five was detected in Gambia in late July.
The government in Banjul announced last month that it was investigating the deaths, and the country’s Health Ministry ordered hospitals to discontinue the use of syrup-based paracetamol treatment after at least 28 children died of kidney failure.
Gambia is already struggling with a number of public health crises, including measles and malaria.
The World Health Organisation has issued a warning concerning four medicines produced by Delhi-based Maiden Pharmaceuticals.
Since July, at least 66 infants have died in Gambia as a result of acute kidney injury, according to the WHO.
The deaths of 66 children from kidney injuries may be linked to four cough and cold syrups made by an Indian drug manufacturer, the World Health Organization (WHO) said on Wednesday.
WHO Director-General Tedros Adhanom Ghebreyesus said the UN’s health agency was conducting investigations along with Indian regulators and India’s Maiden Pharmaceuticals.
[wonderplugin_video iframe=”https://youtu.be/othGdXmc04o” lightbox=0 lightboxsize=1 lightboxwidth=960 lightboxheight=540 autoopen=0 autoopendelay=0 autoclose=0 lightboxtitle=”” lightboxgroup=”” lightboxshownavigation=0 showimage=”” lightboxoptions=”” videowidth=600 videoheight=400 keepaspectratio=1 autoplay=0 loop=0 videocss=”position:relative;display:block;background-color:#000;overflow:hidden;max-width:100%;margin:0 auto;” playbutton=”https://www.tvcnews.tv/wp-content/plugins/wonderplugin-video-embed/engine/playvideo-64-64-0.png”]
The WHO issued a medical product alert, requesting that four medications manufactured by Maiden Pharmaceuticals be removed off the market.
The medicines have only been identified in Gambia, according to the alert, although they may have been distributed in other nations via informal marketplaces.
The four products identified by the alert were: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.
The UN agency said its lab analysis confirmed the presence of “unacceptable” amounts of diethylene glycol and ethylene glycol.
The alert said that the two substances are toxic to humans and can cause acute kidney injury.
“To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the alert said.
A spike in cases of acute kidney injury among children under the age of five was detected in Gambia in late July.
The government in Banjul announced last month that it was investigating the deaths, and the country’s Health Ministry ordered hospitals to discontinue the use of syrup-based paracetamol treatment after at least 28 children died of kidney failure.
Gambia is already struggling with a number of public health crises, including measles and malaria.
The World Health Organisation has issued a warning concerning four medicines produced by Delhi-based Maiden Pharmaceuticals.
Since July, at least 66 infants have died in Gambia as a result of acute kidney injury, according to the WHO.
The deaths of 66 children from kidney injuries may be linked to four cough and cold syrups made by an Indian drug manufacturer, the World Health Organization (WHO) said on Wednesday.
WHO Director-General Tedros Adhanom Ghebreyesus said the UN’s health agency was conducting investigations along with Indian regulators and India’s Maiden Pharmaceuticals.
[wonderplugin_video iframe=”https://youtu.be/othGdXmc04o” lightbox=0 lightboxsize=1 lightboxwidth=960 lightboxheight=540 autoopen=0 autoopendelay=0 autoclose=0 lightboxtitle=”” lightboxgroup=”” lightboxshownavigation=0 showimage=”” lightboxoptions=”” videowidth=600 videoheight=400 keepaspectratio=1 autoplay=0 loop=0 videocss=”position:relative;display:block;background-color:#000;overflow:hidden;max-width:100%;margin:0 auto;” playbutton=”https://www.tvcnews.tv/wp-content/plugins/wonderplugin-video-embed/engine/playvideo-64-64-0.png”]
The WHO issued a medical product alert, requesting that four medications manufactured by Maiden Pharmaceuticals be removed off the market.
The medicines have only been identified in Gambia, according to the alert, although they may have been distributed in other nations via informal marketplaces.
The four products identified by the alert were: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.
The UN agency said its lab analysis confirmed the presence of “unacceptable” amounts of diethylene glycol and ethylene glycol.
The alert said that the two substances are toxic to humans and can cause acute kidney injury.
“To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the alert said.
A spike in cases of acute kidney injury among children under the age of five was detected in Gambia in late July.
The government in Banjul announced last month that it was investigating the deaths, and the country’s Health Ministry ordered hospitals to discontinue the use of syrup-based paracetamol treatment after at least 28 children died of kidney failure.
Gambia is already struggling with a number of public health crises, including measles and malaria.
The World Health Organisation has issued a warning concerning four medicines produced by Delhi-based Maiden Pharmaceuticals.
Since July, at least 66 infants have died in Gambia as a result of acute kidney injury, according to the WHO.
The deaths of 66 children from kidney injuries may be linked to four cough and cold syrups made by an Indian drug manufacturer, the World Health Organization (WHO) said on Wednesday.
WHO Director-General Tedros Adhanom Ghebreyesus said the UN’s health agency was conducting investigations along with Indian regulators and India’s Maiden Pharmaceuticals.
[wonderplugin_video iframe=”https://youtu.be/othGdXmc04o” lightbox=0 lightboxsize=1 lightboxwidth=960 lightboxheight=540 autoopen=0 autoopendelay=0 autoclose=0 lightboxtitle=”” lightboxgroup=”” lightboxshownavigation=0 showimage=”” lightboxoptions=”” videowidth=600 videoheight=400 keepaspectratio=1 autoplay=0 loop=0 videocss=”position:relative;display:block;background-color:#000;overflow:hidden;max-width:100%;margin:0 auto;” playbutton=”https://www.tvcnews.tv/wp-content/plugins/wonderplugin-video-embed/engine/playvideo-64-64-0.png”]
The WHO issued a medical product alert, requesting that four medications manufactured by Maiden Pharmaceuticals be removed off the market.
The medicines have only been identified in Gambia, according to the alert, although they may have been distributed in other nations via informal marketplaces.
The four products identified by the alert were: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.
The UN agency said its lab analysis confirmed the presence of “unacceptable” amounts of diethylene glycol and ethylene glycol.
The alert said that the two substances are toxic to humans and can cause acute kidney injury.
“To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the alert said.
A spike in cases of acute kidney injury among children under the age of five was detected in Gambia in late July.
The government in Banjul announced last month that it was investigating the deaths, and the country’s Health Ministry ordered hospitals to discontinue the use of syrup-based paracetamol treatment after at least 28 children died of kidney failure.
Gambia is already struggling with a number of public health crises, including measles and malaria.
The World Health Organisation has issued a warning concerning four medicines produced by Delhi-based Maiden Pharmaceuticals.
Since July, at least 66 infants have died in Gambia as a result of acute kidney injury, according to the WHO.
The deaths of 66 children from kidney injuries may be linked to four cough and cold syrups made by an Indian drug manufacturer, the World Health Organization (WHO) said on Wednesday.
WHO Director-General Tedros Adhanom Ghebreyesus said the UN’s health agency was conducting investigations along with Indian regulators and India’s Maiden Pharmaceuticals.
[wonderplugin_video iframe=”https://youtu.be/othGdXmc04o” lightbox=0 lightboxsize=1 lightboxwidth=960 lightboxheight=540 autoopen=0 autoopendelay=0 autoclose=0 lightboxtitle=”” lightboxgroup=”” lightboxshownavigation=0 showimage=”” lightboxoptions=”” videowidth=600 videoheight=400 keepaspectratio=1 autoplay=0 loop=0 videocss=”position:relative;display:block;background-color:#000;overflow:hidden;max-width:100%;margin:0 auto;” playbutton=”https://www.tvcnews.tv/wp-content/plugins/wonderplugin-video-embed/engine/playvideo-64-64-0.png”]
The WHO issued a medical product alert, requesting that four medications manufactured by Maiden Pharmaceuticals be removed off the market.
The medicines have only been identified in Gambia, according to the alert, although they may have been distributed in other nations via informal marketplaces.
The four products identified by the alert were: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.
The UN agency said its lab analysis confirmed the presence of “unacceptable” amounts of diethylene glycol and ethylene glycol.
The alert said that the two substances are toxic to humans and can cause acute kidney injury.
“To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the alert said.
A spike in cases of acute kidney injury among children under the age of five was detected in Gambia in late July.
The government in Banjul announced last month that it was investigating the deaths, and the country’s Health Ministry ordered hospitals to discontinue the use of syrup-based paracetamol treatment after at least 28 children died of kidney failure.
Gambia is already struggling with a number of public health crises, including measles and malaria.
The World Health Organisation has issued a warning concerning four medicines produced by Delhi-based Maiden Pharmaceuticals.
Since July, at least 66 infants have died in Gambia as a result of acute kidney injury, according to the WHO.
The deaths of 66 children from kidney injuries may be linked to four cough and cold syrups made by an Indian drug manufacturer, the World Health Organization (WHO) said on Wednesday.
WHO Director-General Tedros Adhanom Ghebreyesus said the UN’s health agency was conducting investigations along with Indian regulators and India’s Maiden Pharmaceuticals.
[wonderplugin_video iframe=”https://youtu.be/othGdXmc04o” lightbox=0 lightboxsize=1 lightboxwidth=960 lightboxheight=540 autoopen=0 autoopendelay=0 autoclose=0 lightboxtitle=”” lightboxgroup=”” lightboxshownavigation=0 showimage=”” lightboxoptions=”” videowidth=600 videoheight=400 keepaspectratio=1 autoplay=0 loop=0 videocss=”position:relative;display:block;background-color:#000;overflow:hidden;max-width:100%;margin:0 auto;” playbutton=”https://www.tvcnews.tv/wp-content/plugins/wonderplugin-video-embed/engine/playvideo-64-64-0.png”]
The WHO issued a medical product alert, requesting that four medications manufactured by Maiden Pharmaceuticals be removed off the market.
The medicines have only been identified in Gambia, according to the alert, although they may have been distributed in other nations via informal marketplaces.
The four products identified by the alert were: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.
The UN agency said its lab analysis confirmed the presence of “unacceptable” amounts of diethylene glycol and ethylene glycol.
The alert said that the two substances are toxic to humans and can cause acute kidney injury.
“To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products,” the alert said.
A spike in cases of acute kidney injury among children under the age of five was detected in Gambia in late July.
The government in Banjul announced last month that it was investigating the deaths, and the country’s Health Ministry ordered hospitals to discontinue the use of syrup-based paracetamol treatment after at least 28 children died of kidney failure.
Gambia is already struggling with a number of public health crises, including measles and malaria.
Related posts:
India halts production of cough syrup linked to deaths in Gambia
India mandates companies to test Cough Syrup before export
Customs impounds 498 cartons of Codeine cough syrup
India says cough syrups met safety specifications
NAFDAC issues warning on four defective baby cough syrups in circulation
Gambia Court issues warrant against accused two ex-army officers
Mass deaths in Kano linked to COVID-19- PTF
Katsina govt confirms 83 deaths linked to diphtheria, intensifies vaccination
